Adenoacanthoma is malignancy of squamous cells that have differentiated from epithelial cells.[1][2][3] It can be present in the endothelium of the uterus, mouth and large intestine.
| Adenoacanthoma | |
|---|---|
| Specialty | Oncology |
| Symptoms | Headaches - Nausea - Blurred vision - vomiting - seizures& personality change are usual symptoms of Adenoacanthoma. |
| Causes | Though the case of the malignant tumor Adenoacanthoma has not been fully identifies it accompanies Endometriosis (a disease in which tissue similar to the lining of the uterus grows outside the uterus.) |
Cause
editThis section is empty. You can help by adding to it. (August 2017) |
Treatment
editIf the tumor is well-defined, the treatment is often includes a hysterectomy and radiation treatment. Treatment may vary according to how far the tumor has spread.
Prognosis
editPrognosis is dependent upon the presence and abundance of glandular cells.[citation needed] Outcomes improve if the tumor is well-defined.
Epidemiology
editIt is associated with hormone replacement therapy (estrogen). The risk is higher in white women than other ethnicities, incidence, prevalence, age distribution, and sex ratio
References
edit- ^ Venes, Donald (2013). Taber's cyclopedic medical dictionary. Philadelphia: F.A. Davis. p. 48. ISBN 9780803629776.
- ^ "adenoacanthoma - Wiktionary". Retrieved 2017-02-19.
- ^ "Adenoacanthoma Medical Definition". Merriam-Webster Medical Dictionary. Retrieved 2017-02-19.
External links
edit- Gynecologic Oncology Group an NIH-Funded research group that runs clinical trials
- CancerNet an NIH database with clinical and scientific information
- PubMed a search engine and database for Medical Literature
 | This oncology article is a stub. You can help Wikipedia by expanding it. |